RxDoctor Payments Data

Arthur Hale, MD

Family Medicine · Branson, MONPI 1346330784

Payments from drug & device makers

$441in general payments, 2019–2025

Across 22 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$84
  • Axsome Therapeutics, Inc.$52
  • Novo Nordisk$52
  • AstraZeneca$49
  • Exact Sciences$37
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35
  • plus $131 from 6 others

What the payments were for

  • Food & beverage$441100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$441 in reported general payments places this provider in the 50th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$140,326
Medicare patients
494
Services billed
6,585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban265$297,396
OzempicSemaglutide125$177,467
TrulicityDulaglutide66$132,125
JardianceEmpagliflozin97$122,394
Trelegy ElliptaFluticasone/Umeclidin/Vilanter144$120,853
XareltoRivaroxaban57$47,590
SymbicortBudesonide/Formoterol Fumarate81$29,899
MounjaroTirzepatide28$28,885
Spiriva HandihalerTiotropium Bromide23$28,500
LinzessLinaclotide32$25,378
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr45$22,357
Breo ElliptaFluticasone/Vilanterol41$21,257
FanaptIloperidone13$20,961
Spiriva RespimatTiotropium Bromide22$19,614
FarxigaDapagliflozin Propanediol14$16,089

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Premarin$20$311,422314 claims
Novo NordiskOzempic, Levemir$52$186,538144 claims
Lilly USA, LLCTrulicity, Mounjaro$84$161,00994 claims
AstraZenecaSymbicort, Farxiga$49$45,98895 claims
Vanda Pharmaceuticals Inc.Fanapt$28$20,96113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Branson

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →